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Edited by Hans EklundAbstract The ErbB-3 receptor binding protein (Ebp1) is a
member of the proliferation-associated 2G4 (PA2G4) family
implicated in regulation of cell growth and diﬀerentiation. Here,
we report the crystal structure of the human Ebp1 at 1.6 A˚ res-
olution. The protein has the conserved pita bread fold of methi-
onine aminopeptidases, but without the characteristic enzymatic
activity. Moreover, Ebp1 is known to interact with a number of
proteins and RNAs involved in either transcription regulation or
translation control. The structure provides insights in how Ebp1
discriminates between its diﬀerent interaction partners.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Proliferation-associated 2G4 proteins (PA2G4) are highly
conserved in eukaryotes and involved in the regulation of cell
growth and diﬀerentiation [1,2]. The human member of this
family, ErbB3 binding protein 1 (Ebp1), is ubiquitously
expressed and localizes in both nucleus and cytoplasm [3]. It
was initially identiﬁed to bind to the juxtamembrane domain
of non-phosphorylated ErbB3 receptors [4]. Ectopic expression
inhibits the growth of human breast and prostate cancer cells
and induces cellular diﬀerentiation [5]. Treatment of serum-
starved human breast cancer cells with the ErbB3/4 ligand
heregulin (HRG) induces translocation of Ebp1 from cyto-
plasm to nucleus [4]. In the nucleus Ebp1 is involved in tran-
scriptional regulation by interaction with Sin3A [6], Akt [7],
Rb and histone deacetylase 2 (HDAC2) on E2F promoters [8].
The protein binds structured RNAs [3,9–11] and was sug-
gested to be involved in linking ribosome biosynthesis and cell
proliferation [3]. The yeast member of the PA2G4 family,Abbreviations: Ebp1, ErbB3 binding protein 1; PA2G4, proliferation
associated 2G4; IRES, internal ribosomal entry site; MAP, methionine
aminopeptidase; eIF, eukaryotic initiation factor; ITAF, IRES trans
acting factor
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doi:10.1016/j.febslet.2007.08.024Arx1, which is associated with a late pre-60S particle, func-
tions as a nuclear export receptor for the large ribosomal sub-
unit [12]. Ebp1 was shown to act as a cellular inhibitor of the
eukaryotic initiation factor (eIF) 2a phosphorylation suggest-
ing a role in protein translation control [11]. The protein has
been identiﬁed as an IRES-trans-acting factor (ITAF45) [10].
Internal ribosomal entry site (IRES) elements consist of highly
structured RNA regions located at the 5 0 UTR of viral or cel-
lular mRNAs. Initiation of translation from IRES elements is
mediated by a set of canonical eIFs and a series of message
speciﬁc cellular ITAFs. Thus, the RNA binding activity of
Ebp1 could be critical for its cellular function as a modulator
of stability and translation of speciﬁc mRNAs [11]. To gain
insight into the multiple roles of this conserved protein family,
we determined the atomic structure of human Ebp1.2. Materials and methods
2.1. Structure determination
Ebp1 was cloned, expressed, puriﬁed and crystallized as described
elsewhere [13]. The structure was solved by molecular replacement with
CCP4 implemented PHASER [14], using the structure of the methio-
nine aminopeptidase from Pyrococcus furiosus (PDB code: 1wkm)
[15] as a search model. The sequence identity between search model
and Ebp1 is 24%. The asymmetric unit contains one molecule. The
crystal solvent content was 56%. Model building was initially
performed automatically with program wARP [16] and completed
manually with COOT [17] and O [18]. The structure was reﬁned with
program REFMAC [19] and validated with programs PROCHECK
[20] and WHATIF [21]. Reﬁnement statistics are listed in Supplemen-
tary Table 1. Residues 83 and 274 appeared as outliers in the Rama-
chandran plot, however, they were well deﬁned in the electron
density. Illustrations were prepared with PYMOL [22] and GRASP
[23].
2.2. Methionine amino peptidase activity assay
The coupled enzymatic assay for monitoring methionine aminopep-
tidase activity was performed as described [24]. The assay contained
50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 50 lMAmplex Red (Molec-
ular Probes), 5 U AAO (Worthington), 1 U Horse Radish Peroxidase
(Fluka), 0.3 mM L-Met-Ala-Ser (Sigma). The concentrations of MAP1
and Ebp1 were 100 nM and 130 nM, respectively. Emission at 590 nm
was measured in a Jasco FP-6500 spectroﬂuorometer (578 nm excita-
tion).2.3. Polysome puriﬁcation
Ebp1 was expressed under the ADH1 promoter as a TAP-Flag
tagged fusion protein from pYCplac111-PADH1-NTAPFlag-EBP1
in an ARX1 deletion Saccharomyces cerevisiae strain (arx1D DS1-2b
[12]). Lysate preparation and sucrose density gradient centrifugation
were performed as described [25]. The TCA-precipitated fractions were
analyzed by SDS–PAGE and Western blot analysis using anti-Rpl3
antibody and anti-PAP antibody to detect tagged Ebp1.blished by Elsevier B.V. All rights reserved.
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RNA bandshift assays were carried out as described [26]. Yeast 5S
rRNA was produced by in vitro transcription as described [26]. Total
yeast tRNA was ordered from Sigma. The SRP-RNA construct (95
nucleotides) consisted of the highly conserved SRP core of Sulfolobus
solfataricus (Bange & Sinning, unpublished). RNA was incubated with
increasing concentrations of recombinant protein.Fig. 2. Comparison of the central cavity in Ebp1 and MAP2. (A)
Residues involved in metal binding and catalysis in MAP2 (pdb code:
1kq9) are shown. (B) The same region and orientation as in (A) is
shown for Ebp1. For comparison the metal ions are included from a
superposition with MAP2. The e-amino group of Lys320 (adopting
two alternative conformations) is occupying the metal binding site.
Final 2FO–FC electron density for Lys320 is contoured at 1.5r. (C)
The substrate binding site of MAP2 is shown with bound Zn ions and
methionine. (D) The hydrophobic binding site of Ebp1 with methio-
nine placed from superposition with MAP2. Phe76 has a diﬀerent
conformation than the corresponding Phe219 in the MAP2/methionine
complex and might block the binding site as suggested by the clash
with methionine. In MAP2, residues involved in ligand binding are:
Phe219 (Phe76), His231 (His88), Asp251 (Asp109), Ile338 (Ile195),
His339 (Asp196), His382 (Ile246) and Tyr444 (Phe305) (corresponding
residues in Ebp1 are given in brackets).3. Results and discussion
3.1. Ebp1 shares the pita-bread fold of methionine
aminopeptidases
The crystal structure of the human PA2G4 homologue,
Ebp1, was determined at 1.6 A˚ resolution (Supplementary
Table 1). The atomic coordinates and structure factors have
been deposited in the Protein Data Bank under the accession
code: 2Q8K. The structure reveals a pita-bread fold as con-
served in methionine aminopeptidases (MAP), prolidase, crea-
tinase and amino peptidase P [27] (Fig. 1). Human MAP2 was
identiﬁed as the closest structural homologue of Ebp1 by the
program DALI [28] with an root mean square deviation
(r.m.s.d.) of 2.0 A˚ over 299 residues. Like MAP2, Ebp1 con-
tains an insert domain (residues: 244–305) of unknown func-
tion. Despite the high degree of structural conservation,
Ebp1 shows a rather low sequence identity (less than 25%) with
members of the MAP family (see sequence alignment and
superposition in Supplementary Figs. 1 and 2, respectively).
3.2. Ebp1 does not show methionine aminopeptidase activity
A major structural feature of pita-bread enzymes is a large
cavity primarily formed by the inner surface of the central
beta-barrel (b-sheets 1, 3, 4, 5, 7 and 13 in Ebp1, Fig. 1). In
MAP2, this cavity harbors the active site and adjacent ele-
ments for substrate recognition/binding. In all enzymes of this
family (except creatinase), a divalent metal centre within the
active site is involved in the hydrolytic cleavage of the sub-
strate [27]. The two metal ions in human MAP2 are bound
by monodentate (His331, and Glu364) and bidentate
(Asp251, Asp262, and Glu459) ligation [24] (Fig. 2A). InFig. 1. Structure of Ebp1. (A) Ebp1 is shown in a ribbon represen-
tation, with the beta barrel forming the hydrophobic cavity in the
center (indicated by an arrow). The pita-bread domain is coloured in
blue, the insert domain in orange, the b-sheet connecting these
domains in green, the Ebp1 speciﬁc helix at the entrance of the cavity
in turquoise and the C-terminal elongation in red. (B) Topology
diagram of Ebp1. For clarity the orientation is chosen 90 rotated
compared to (A). b-Strands are represented by arrows and triangles, a-
helices by cylinders and circles, and 310 helices by hexagons.Ebp1, the metal ions are not present in the crystal structure
and only two of the metal coordinating residues are conserved
(Asp109 and His188) (Fig. 2A and B). Two negatively charged
residues (Asp262, Glu364) in MAP2 are replaced by Asn120
and Asp227 in Ebp1. The most signiﬁcant diﬀerence, however,
is the change from Glu459 in MAP2 to Lys320 in Ebp1. The
positive charge and the length of the Lys320 side chain hinder
metal coordination both electrostatically and sterically
(Fig. 2A and B). Thus, Ebp1 should not be able to perform
hydrolytic substrate cleavage which was conﬁrmed by a methi-
onine aminopeptidase assay with a common MAP substrate
(Fig. 3A).
3.3. The substrate binding pocket of methionine aminopeptidases
is conserved in Ebp1
In MAP2, the substrate binding pocket is adjacent to the
divalent metal ion binding site. The overall hydrophobic char-
acter of the methionine binding site as well as the electrostatic
character of the cavity seems conserved in Ebp1 (Fig. 2C and
D). This suggests that methionine or a small hydrophobic li-
gand should be able to bind. In MAP2, Phe219 and Ile338
are involved in hydrophobic interactions with the side chain
of a bound methionine. In Ebp1 both residues are conserved
(Phe76 and Ile195). However, the side chain of Phe76 has a dif-
ferent orientation with respect to Phe219 in the MAP2/methio-
Fig. 3. Biochemical properties of Ebp1. (A) Ebp1 does not display MAP activity. The recombinant proteins were added to the MAP enzymatic assay
at the indicated time point. (B) Ebp1 binds to ribosomal 5S rRNA. RNA bandshift assays with increasing concentrations of Ebp1 with 5S rRNA
(19.5 ng/ll, upper panel), tRNA (73.5 ng/ll, middle panel) and SRP-RNA (87 ng/ll, lower panel). (C) Ebp1 co-localizes with monosomal and
polysomal ribosome fractions on a sucrose gradient. Western blot analysis was conducted using anti-PAP and anti-Rpl3 antibodies.
Fig. 4. Localisation of a putative RNA binding site in Ebp1. The
protein is shown in a surface representation viewed from the back
opposite to the central cavity. An elongated positively charged patch
indicates a putative RNA binding site with two bound sulfate ions (S1,
S2). The C-terminal helix a10 with the ‘LXXLL’ motif and the
phosphorylation site (Ser360) are shown. The electrostatic surface
potential was calculated using Grasp [34]. Positive and negative
charges are in blue and red, respectively.
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phobic cavity of Ebp1 according to the MAP2/methionine
complex, Phe76 would sterically clash with the ligand. Binding
of a ligand including a terminal methionine might however be
possible in Ebp1 upon rotation of Phe76. Choosing the same
side chain rotamer for Phe76 as observed for Phe219 in the
MAP2/methionine structure would be enough to remove the
clash. However, in co-crystallization trials or crystal soaking
experiments of Ebp1 with methionine, no additional electron
density could be observed and the central cavity was still
blocked by Phe76 (not shown). In addition, binding to a subset
of FG repeats of nucleoporins, as observed for the yeast homo-
logue Arx1p, could not be observed for Ebp1 [12]. However, it
seems unlikely that such a specialized binding cavity is
conserved without a speciﬁc function. Substrate binding might
require a conformational change in Ebp1 induced upon
interaction with another factor. Notably, an Ebp1 speciﬁc
insertion is found at the entrance of the central cavity (helix
a5, Fig. 1A and B). Helix a5 is polar and contains positively
charged residues (Lys) as often found in RNA interaction sites
and might be employed in substrate recognition. Although
speculative, we propose that an initiator methionine-tRNA
(for tRNA interaction see below) might utilize both helix a5
and the hydrophobic cavity. This would be in line with a role
of Ebp1 in controlling the functional state of particular inter-
nal ribosomal entry sites (IRES) [10].
3.4. Ebp1 has a speciﬁc C-terminal elongation
In addition to the human MAP2 fold, Ebp1 contains a C-
terminal elongation of 57 residues. Part of it is ordered in
the crystal structure (residues 340–362) and attaches a short
amphipathic a-helix (a10) to the outer face of the second half
of the pita-bread fold (Figs. 1 and 4). Helix a10 contains theLXXLL motif, a binding motif of co-activators of nuclear
receptors [29–31]. Mutation of this motif to LXXAA inhibits
an interaction between Ebp1 and the PAH4 domain of the
transcription factor Sin3A [6]. Moreover, a PKC phosphoryla-
tion site at Ser360 [7,32] is found after helix a10 and marks the
end of the globular fold of Ebp1 (Fig. 4). Ebp1 S360A, which
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S360D, which mimics phosphorylation, strongly binds nuclear
Akt and inhibits apoptosis [7]. Thus, helix a10 together with
the adjacent phosphorylation site at Ser360 may provide an
adjustable interface for the interaction of Ebp1 with either
Sin3A or Akt, and consolidates the function of Ebp1 as a
transducer of growth regulatory signals upon dissociation
from the heregulin stimulated ErbB3 receptor.
3.5. Ebp1 binds RNA
Ebp1 is not only involved in transcriptional regulation, but
also seems to participate in protein translation control
[10,11]. The protein binds to a number of RNAs including
mRNA [9,10], rRNA [3] and also ribonucleoprotein complexes
[3,9–11]. Our analyses showed that Ebp1 can interact with 80S
ribosomes and polysomes (Fig. 3B). In addition, recombinant
Ebp1 was incubated with a number of structured RNAs and
analyzed on native PAGE (Fig. 3C). Ebp1 seems to bind stron-
ger to ribosomal 5S RNA when compared to a mixture of t-
RNAs or the S-domain RNA of the signal recognition particle.
These observations point to a direct interaction of Ebp1 with
mature ribosomes via the 5S RNA.
The crystal structure of Ebp1 was analyzed for the location
of putative RNA binding sites. Besides helix a5 (see above) an
extended positively charged surface patch is formed by the
Ebp1 speciﬁc C-terminal extension and a loop insertion (resi-
dues 62–72 in Ebp1) not present in MAP2 (Fig. 4). Two sulfate
ions from the crystallization buﬀer are bound in this area. Sul-
fate 1 (S1) forms a bidentate interaction with Arg33 (helix a3),
while sulfate 2 (S2) is coordinated by Arg332 (sheet b14) and
His147 (helix a3). Both ions are 8 A˚ apart and might mimic
backbone phosphate groups of a bound RNA molecule as of-
ten observed in structures of nucleic acid binding proteins. The
close proximity of this putative RNA binding platform to the
LXXLL motif in helix a10 and the phosphorylation site at
Ser360 gives a ﬁrst idea of how Ebp1 might discriminate be-
tween diﬀerent interaction partners. While the phosphoryla-
tion site at Ser360 might control the accessibility of the
proposed RNA binding site at the positively charged patch,
the central cavity with helix a5 is on the opposite site of
Ebp1. Therefore, a simultaneous interaction with two struc-
tured RNAs, e.g. a t-RNA and ribosomal 5S RNA seems fea-
sible. Whether this occurs in vivo remains to be shown.4. Conclusion
Taken together, Ebp1 is a striking example for the adapta-
tion of a conserved enzyme fold to a multi-functional binding
platform. The observation that the hydrophobic substrate
binding pocket is maintained but the catalytic center is de-
stroyed, suggests that the MAP fold is exploited by a similar
substrate, but in a diﬀerent context. If methionine is indeed
the substrate, this context could be an initiator Met-tRNA.
The initiator Met-tRNA is ideal in delivering a terminal methi-
onine into a deep binding pocket, as the ﬁrst base pair is AU
(instead of normally GC) which can easily be split. This recog-
nition mechanism has been described for the formylation of
bacterial initiator t-RNA [33]. Moreover, the Ebp1 speciﬁc
helix a5 at the entrance of the pocket could interact with the
acceptor helix similarly to an enzyme loop in the bacterialtransformylase. Whether this idea is consistent with the estab-
lished function of Ebp1 in cap-independent translation initia-
tion remains to be clariﬁed. The stage for an in-depth
analysis of Ebp1 as a multi functional binding platform is set.
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